4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-040128
Chief Operating Officer sold 2,642 shares at $0.66 ($1,738)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2024-09-09 | Sale | −2,642 | $0.66 | $1,738 | 289,110 | D |
| Open-market sales · 2,642 sh · avg $0.66 · $1,738 | |||||||
Loading xslF345X05/wk-form4_1726084882.xml…